[1] Yin Y,Liu Y,Zhuang J,et al. Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances[J].Pharmacology,2015,96(3):155-162.
[2] 霍江涛,张小乔,严洁,等. 美金刚联合多奈哌齐治疗中重度阿尔茨海默病的效果观察[J].中国综合临床,2015,31(11):969-972.
[3] Kamp D, Paschali M, Supprian T, et al. Hypothermia in a patient with Alzheimer's disease receiving a combination therapy with risperidone and pipamperone[J].Ther Adv Psychopharmacol,2016,6(1):55-57.
[4] Lee Y, Park J, Lee B, et al. Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-na ve Alzheimer's disease patients[J].J Clin Psychiatry,2016,34(6):8-13.
[5] 王梅平. 美金刚联合盐酸多奈哌齐治疗阿尔茨海默病伴精神行为症状的临床效果观察[J].中国综合临床,2017,33(2):126-130.
[6] 何饶丽,潘晓东,黄天文,等. 美金刚治疗中重度阿尔茨海默病疗效的系统评价[J].中华老年医学杂志,2015,35(6):680-684.
[7] Lavretsky H. Hallucinations predict relapse after discontinuation of risperidone in patients with Alzheimer's disease and psychosis or agitation[J].Ame J Psychiatry,2017,174(4):307-308.
[8] 钟华,刘少华. 奥氮平与利培酮治疗阿尔茨海默病患者伴精神行为症状的效果比较[J].中国当代医药,2015,10(35):145-147.
[9] 雷四英. 阿立哌唑/利培酮联合多奈哌齐治疗阿尔茨海默病的临床观察[J].中国药房,2016,27(2):253-255.
[10] Bloniecki V, Aarsland D, Blennow K, et al. Effects of risperidone and galantamine treatment on Alzheimer's disease biomarker levels in cerebrospinal fluid[J].J Alzheimers Dis,2017,57(2):387-393.
[11] 杨婵娟,张若曦,方雅秀,等. rTMS与利培酮治疗阿尔茨海默病患者精神行为症状的疗效观察[J].中国健康心理学杂志,2015,23(6):817-820. |
2019, Vol. 36 
